Skip Navigation



Rheumatology Advance Access published online on July 27, 2004
Rheumatology, doi:10.1093/rheumatology/keh318
Rheumatology © British Society for Rheumatology 2004; all rights reserved
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
43/9/1069    most recent
keh318v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Dawes, P. T.
Right arrow Articles by Mucklow, J. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dawes, P. T.
Right arrow Articles by Mucklow, J. C.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Editorial

TNF therapy for spondyloarthropathy: can we marshal the argument?

P. T. Dawes 1, J. C. Packham 1, J. C. Mucklow 2*

1 Staffordshire Rheumatology Centre, University Hospital of North Staffordshire NHS Trust, Haywood Hospital, High Lane, Burslem, Stoke on Trent, ST6 7AG, UK
2 Department of Clinical Pharmacology, University Hospital of North Staffordshire NHS Trust, City General Hospital, Stoke on Trent, UK

* To whom correspondence should be addressed. E-mail: PT.Dawes{at}uhns.nhs.uk.


  Abstract

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Rheumatology (Oxford)Home page
E. Collantes-Estevez, M. C. Munoz-Villanueva, P. Zarco, J. C. Torre-Alonso, J. Gratacos, C. Gonzalez, R. Sanmarti, J. D. Canete, and (Spanish Spondyloarthropathies Study Group)
Effectiveness of reducing infliximab dose interval in non-responder patients with refractory spondyloarthropathies. An open extension of a multicentre study
Rheumatology, December 1, 2005; 44(12): 1555 - 1558.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.